Revenue $11.99B, up 10.5% on a year earlier. Analytical Instruments segment revenue $1.85B, down 2.4%. Laboratory Products and Services segment revenue $6.69B, up 11.6%. Diluted EPS $4.68 against $4.28.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $10.86B | +10.5% |
| Operating income | $2.09B | $1.86B | $1.83B | +13.7% |
| Net income | $1.74B | $1.66B | $1.62B | +7.5% |
| Diluted EPS | $4.68 | $4.43 | $4.28 | |
| Operating cash flow | $2.12B | $1.19B | $1.40B | +51.9% |
| Capital expenditures | -$450.00M | -$376.00M | -$294.00M | |
| Free cash flow | $1.68B | $816.00M | $1.10B | +51.6% |
| Dividend per share | $0.47 | $0.47 | $0.43 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Analytical Instruments segment revenue | $1.85B | $1.89B | -2.4% |
| Laboratory Products and Services segment revenue | $6.69B | $6.00B | +11.6% |
| Life Sciences Solutions segment revenue | $2.81B | $2.59B | +8.8% |
| Revenue Growth | 10% | 2.98% | |
| Currency translation impact on revenue | 1% | 1% | |
| Organic revenue growth | 5% | 2% | |
| Core organic revenue growth | 5% | 2% | |
| Specialty Diagnostics segment revenue | $1.21B | $1.17B | +2.6% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Thermo Fisher Scientific (TMO) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/TMO/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
